# Older Cannabis Users: Benefits for Dispensaries, Concerns for Doctors

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/older-adults-cannabis-dosing-safety-clinical-challenges/
> **Published:** 2026-03-16T08:30:14-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:06:59-04:00
> **Clinical Summary:** Explore older adults cannabis dosing safety and clinical challenges for doctors amid growing dispensary markets and limited geriatric data.

---

✦ New

 CED Clinical Relevance
 #65
 Notable Clinical Interest
 Emerging findings or policy developments worth monitoring closely.

AgingDosingSafetyIndustry

 Why This Matters
 Older adults represent a growing market for dispensaries but present clinical challenges due to limited safety data, drug-drug interactions, and age-related pharmacokinetic changes that clinicians must understand to counsel patients appropriately. This demographic shift requires physicians to develop evidence-based guidelines for cannabis dosing and monitoring in elderly patients, particularly those on multiple medications or with cognitive or fall risk concerns. Clinicians need training on cannabinoid pharmacology and state medical marijuana programs to provide informed recommendations and reduce potential adverse outcomes in this vulnerable population.

 Clinical Summary
 

This article highlights the growing demographic of older adults obtaining [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) cards and increasing their consumption patterns, which represents a significant market opportunity for dispensaries but raises clinical concerns for healthcare providers. Older patients, exemplified by users consuming 40-50 mg daily through multiple product forms, may be at heightened risk for adverse effects including [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), falls, drug interactions, and cannabinoid hyperemesis syndrome due to age-related pharmacokinetic changes and polypharmacy. The expansion of medical [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) has created a situation where older adults can access cannabis without necessarily consulting their primary care physicians or geriatricians, potentially leading to unmonitored use and inadequate assessment of risks versus benefits in this vulnerable population. Unlike traditional pharmaceuticals, cannabis products lack standardized dosing guidance and clear efficacy data for common geriatric conditions, making it difficult for physicians to counsel patients on appropriate use or monitor for harms. Clinicians caring for older adults should proactively screen for cannabis use at each visit, understand the pharmacology and potential interactions with common medications, and engage in shared decision-making conversations about safer alternatives when appropriate. Given the gap between dispensary promotion and medical oversight, physicians need to take an active role in educating older patients about dosing safety and monitoring their cannabis consumption as part of comprehensive medication management.

 Dr. Caplan’s Take
 “We’re seeing a real clinical problem: older patients are self-titrating to doses that would concern me in younger populations, partly because dispensaries have financial incentives to support higher consumption rather than help them find their minimum effective dose. My job is to help seniors use cannabis safely and effectively, which often means starting low, going slow, and teaching them that more isn’t always better for pain or sleep.”

 Clinical Perspective
 
 

The increasing prevalence of cannabis use among older adults presents a significant clinical challenge as this population seeks alternatives to conventional medications, particularly for pain and anxiety management. While dispensaries benefit from this growing market segment, healthcare providers must contend with several important concerns, including the lack of standardized dosing guidance, limited evidence for safety and efficacy in geriatric populations, and potential drug-drug interactions with the polypharmacy common in this age group. High daily doses like those mentioned in patient reports carry particular risks for older adults, who may experience impaired cognition, falls, orthostatic hypotension, and other adverse effects at lower thresholds than younger users. The gap between patient autonomy in obtaining cannabis through legal channels and clinician knowledge about its effects creates opportunities for suboptimal care and delayed recognition of cannabis-related complications. Healthcare providers should proactively inquire about cannabis use in older patients, counsel on dosing caution, monitor

 

 

💬 Join the Conversation

 

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

 

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Older+cannabis+users+good+for+dispensaries%2C+concerning+for+doctors+-+The+Boston+Globe+%40drcaplan&url=https%3A%2F%2Fwww.bostonglobe.com%2F2026%2F03%2F16%2Fbusiness%2Fsenior-cannabis-dispensaries-medical%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.bostonglobe.com%2F2026%2F03%2F16%2Fbusiness%2Fsenior-cannabis-dispensaries-medical%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Older+cannabis+users+good+for+dispensaries%2C+concerning+for+doctors+-+The+Boston+Globe+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.bostonglobe.com%2F2026%2F03%2F16%2Fbusiness%2Fsenior-cannabis-dispensaries-medical%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

 Related Articles
 
- [AM News Update: March 16, 2026](https://cedclinic.com/cannabis-use-by-older-adults-mental-decline-2026/)

📰 Source: [https://www.bostonglobe.com/2026/03/16/business/senior-cannabis-dispensaries-medical/](https://www.bostonglobe.com/2026/03/16/business/senior-cannabis-dispensaries-medical/)

 Further Reading
 Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
 Research Digest[AM Policy Update: March 16, 2026](https://cedclinic.com/dea-scheduling-cannabis-rescheduling-march-16-2026/)
 Evidence Watch[AM Study Update: March 16, 2026](https://cedclinic.com/cannabis-research-clinical-update-march-16-2026/)

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.

 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 

 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 

 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Older Adults Turn to Cannabis Primarily for Symptom Management](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management/)

Explore how older adults are increasingly using cannabis for managing symptoms and the implications for clinical care.

[Read More](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management/)

[With cannabis, seniors find relief but not enough oversight – The Boston Globe](https://cedclinic.com/cannabis-clinical-oversight-seniors-relief-safety/)

An in-depth look at how seniors use cannabis for relief and the gaps in medical oversight that need addressing.

[Learn More](https://cedclinic.com/cannabis-clinical-oversight-seniors-relief-safety/)

[Why Older Adults Increasingly Seek Cannabis for Pain, Mental Health, & Sleep](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/)

Understanding the reasons behind the rising cannabis use among older adults for pain, mental health, and sleep issues.

[Discover Insights](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
